Michael B Boffa

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 4

Top Topics

Fluorescence Imaging

Endothelial Cells

Top Venues

Clinical & experimental metastasis

Journal of thrombosis and thrombolysis

Arteriosclerosis, thrombosis, and vascular biology

Journal of neurointerventional surgery

University of Western Ontario

Queen's University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Western Ontario Jul 1o 2016

Canada

Associate Professor :: Biochemistry

Education History

Queen's University Sep 1o 1994 - Jan 30o 2000

Canada

PHD :: Biochemistry

Publications

Justin J W Garabon, Michael B Boffa
Profibrinolytic effects of rivaroxaban are mediated by thrombin-activatable fibrinolysis inhibitor and are attenuated by a naturally occurring stabilizing mutation in enzyme. Journal of thrombosis and thrombolysis (2023)
Amer Youssef, Justin R Clark, Santica M Marcovina, Michael B Boffa, Marlys L Koschinsky
Apo(a) and ApoB Interact Noncovalently Within Hepatocytes: Implications for Regulation of Lp(a) Levels by Modulation of ApoB Secretion. Arteriosclerosis, thrombosis, and vascular biology 42 (3) (2022)
Spencer D Christiansen, Junmin Liu, Michael B Boffa, Maria Drangova
Simultaneous R2* and quantitative susceptibility mapping measurement enables differentiation of thrombus hematocrit and age: an in vitro study at 3 T. Journal of neurointerventional surgery 11 (11) (2019)
Zainab A Bazzi, Jennifer Balun, Dora Cavallo-Medved, Lisa A Porter, Michael B Boffa
Activated thrombin-activatable fibrinolysis inhibitor attenuates the angiogenic potential of endothelial cells: potential relevance to the breast tumour microenvironment. Clinical & experimental metastasis 34 (2) (2017)